MULTIPLE CLOSELY-LINKED NFAT-OCTAMER AND HMG I(Y) BINDING-SITES ARE PART OF THE INTERLEUKIN-4 PROMOTER

被引:190
作者
CHUVPILO, S
SCHOMBERG, C
GERWIG, R
HEINFLING, A
REEVES, R
GRUMMT, F
SERFLING, E
机构
[1] UNIV WURZBURG, INST PATHOL,BIOZENTRUM,AM HUBLAND, J SCHNEIDER STR 7, D-97080 WURZBURG, GERMANY
[2] NICHHD, BETHESDA, MD 20892 USA
[3] UNIV WURZBURG, INST BIOCHEM, BIOZENTRUM, D-97080 WURZBURG, GERMANY
关键词
D O I
10.1093/nar/21.24.5694
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We show here that the immediate upstream region (from position -12 to -270) of the murine Interleukin 4 (Il-4) gene harbors a strong cell-type specific transcriptional enhancer. In T lymphoma cells, the activity of the Il-4 promoter/enhancer is stimulated by phorbol esters, Ca++ ionophores and agonists of protein kinase A and inhibited by low doses of the immunosuppressant cyclosporin A. The Il-4 promoter/enhancer is transcriptionally inactive in B lymphoma cells and HeLa cells. DNase I footprint protection experiments revealed six sites of the Il-4 promoter/enhancer to be bound by nuclear proteins from lymphoid and myeloid cells. Among them are four purine boxes which have been described to be important sequence motifs of the Il-2 promoter. They contain the motif GGAAA and are recognized by the inducible and cyclosporin A-sensitive transcription factor NFAT-1. Three of the Il-4 NFAT-1 sites are closely linked to weak binding sites of Octamer factors. Several purine boxes and an AT-rich protein-binding site of the Il-4 promoter are also recognized by the high mobility group protein HMG I(Y). Whereas the binding of NFAT-1 and Octamer factors enhance the activity of the Il-4 promoter, the binding of HMG I(Y) suppresses its activity and, therefore, appears to be involved in the suppression of Il-4 transcription in resting T lymphocytes.
引用
收藏
页码:5694 / 5704
页数:11
相关论文
共 59 条
[1]   AN 11-BASE-PAIR DNA-SEQUENCE MOTIF APPARENTLY UNIQUE TO THE HUMAN INTERLEUKIN-4 GENE CONFERS RESPONSIVENESS TO T-CELL ACTIVATION SIGNALS [J].
ABE, E ;
MALEFYT, RD ;
MATSUDA, I ;
ARAI, K ;
ARAI, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2864-2868
[2]  
ARAI N, 1989, J IMMUNOL, V142, P274
[3]   ACTIVATION OF LYMPHOKINE GENES IN T-CELLS - ROLE OF CIS-ACTING DNA ELEMENTS THAT RESPOND TO T-CELL ACTIVATION SIGNALS [J].
ARAI, N ;
NAITO, Y ;
WATANABE, M ;
MASUDA, ES ;
YAMAGUCHIIWAI, Y ;
TSUBOI, A ;
HEIKE, T ;
MATSUDA, I ;
YOKOTA, K ;
KOYANONAKAGAWA, N ;
LEE, HJ ;
MURAMATSU, M ;
YOKOTA, T ;
ARAI, K .
PHARMACOLOGY & THERAPEUTICS, 1992, 55 (03) :303-318
[4]   REGULATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES - X, Y AND OTHER LETTERS OF THE ALPHABET [J].
BENOIST, C ;
MATHIS, D .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :681-715
[5]  
BETZ M, 1991, J IMMUNOL, V146, P108
[6]   THE NFAT-1 DNA-BINDING COMPLEX IN ACTIVATED T-CELLS CONTAINS FRA-1 AND JUNB [J].
BOISE, LH ;
PETRYNIAK, B ;
MAO, XH ;
JUNE, CH ;
WANG, CY ;
LINDSTEN, T ;
BRAVO, R ;
KOVARY, K ;
LEIDEN, JM ;
THOMPSSON, CB .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (03) :1911-1919
[7]   THE IMMUNOSUPPRESSIVES FK-506 AND CYCLOSPORINE-A INHIBIT THE GENERATION OF PROTEIN FACTORS BINDING TO THE 2 PURINE BOXES OF THE INTERLEUKIN-2 ENHANCER [J].
BRABLETZ, T ;
PIETROWSKI, I ;
SERFLING, E .
NUCLEIC ACIDS RESEARCH, 1991, 19 (01) :61-67
[8]   TRANSFORMING GROWTH-FACTOR-BETA AND CYCLOSPORINE-A INHIBIT THE INDUCIBLE ACTIVITY OF THE INTERLEUKIN-2 GENE IN T-CELLS THROUGH A NONCANONICAL OCTAMER-BINDING SITE [J].
BRABLETZ, T ;
PFEUFFER, I ;
SCHORR, E ;
SIEBELT, F ;
WIRTH, T ;
SERFLING, E .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) :1155-1162
[9]   ONE BASE PAIR CHANGE ABOLISHES THE T-CELL-RESTRICTED ACTIVITY OF A KB-LIKE PROTO-ENHANCER ELEMENT FROM THE INTERLEUKIN-2 PROMOTER [J].
BRIEGEL, K ;
HENTSCH, B ;
PFEUFFER, I ;
SERFLING, E .
NUCLEIC ACIDS RESEARCH, 1991, 19 (21) :5929-5936
[10]   NUCLEOTIDES FLANKING A CONSERVED TAAT CORE DICTATE THE DNA-BINDING SPECIFICITY OF 3 MURINE HOMEODOMAIN PROTEINS [J].
CATRON, KM ;
ILER, N ;
ABATE, C .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (04) :2354-2365